047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Treatment
Heidi Leister-Tebbe, BSN (she/her/hers)
Clinician/Clinical Lead
Pfizer Inc
Collegeville, Pennsylvania, United States
Weihang Bao, PhD
Pfizer Inc
New York, New York, United States
Robert Fountaine, PharmD
Pfizer Inc
Groton, Connecticut, United States
Mary Lynn Baniecki, PhD
Head of Infectious Disease for Translational Medicine
Pfizer Inc
Cambridge, Massachusetts, United States
Victoria Hendrick, BSc
Pfizer
Sandwich, England, United Kingdom
Wayne Wisemandle, MA
Pfizer Inc
Wake Forest, Illinois, United States
Jennifer Hammond, PhD
Head of Antiviral Development
Pfizer Inc
Collegeville, PA, United States
James Rusnak, MD, PhD
Pfizer Inc
Tampa, Florida, United States